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Impact of COVID‐19 pandemic: isolation, impairment of well‐being, and insecurity {#ehf212871-sec-0001}
================================================================================

With the current COVID‐19 pandemic, unprecedented restrictions have been decided by governmental authorities on social freedoms in order to allow strict social distancing to reduce transmission of SARS‐CoV‐2 and risk of COVID‐19 spread.[^1^](#ehf212871-bib-0001){ref-type="ref"} These measures aim to drastically reduce social interactions (school shutdown and home working), prohibiting visits from relatives and minimizing the use of public transports, and were gradually adopted worldwide. In certain countries, especially in Europe, containment restrictions were severe with the entire population advised to stay at home.

The psychological effects of containment/quarantine have been recently described revealing numerous emotional consequences, including stress and fear, depression and insomnia, anger and irritability, frustration, and boredom with possible persisting sequelae even after the quarantine was lifted. A greater duration of confinement, inadequate supplies, limited access to medical care and medications, and financial losses are aggravating factors.[^2^](#ehf212871-bib-0002){ref-type="ref"}

Fear, uncertainty on the future, unclear or even contradictory messages from the authorities, and continuous and alarming media reports (daily number of deaths and insecurity) may play an additional impact on the emergence of emotional stress.[^3^](#ehf212871-bib-0003){ref-type="ref"}

Takotsubo physiopathology and role of stressful event {#ehf212871-sec-0002}
=====================================================

The pathophysiology of takotsubo syndrome (TTS) is complex and still not fully understood, but the role of stress and its interaction with the autonomic nervous system seems predominant.

An increase in circulating and intracardiac catecholamines has been frequently described, as well as a modification of the activity of G proteins coupled to B~2~ receptors.[^4^](#ehf212871-bib-0004){ref-type="ref"} Animal TTS models (immobilization stress) have demonstrated a protective effect of beta‐blockers and alpha‐blockers,[^5^](#ehf212871-bib-0005){ref-type="ref"} which is also suspected in humans at the acute stage of TTS but does not persist in the long term.[^6^](#ehf212871-bib-0006){ref-type="ref"} Chronic stress (dependent, cancer and depression) seems to facilitate TTS occurrence.[^7^](#ehf212871-bib-0007){ref-type="ref"} An acute emotional or physical trigger is found in almost 50% of TTS cases.[^8^](#ehf212871-bib-0008){ref-type="ref"}

Impact of COVID‐19 pandemic on TTS occurrence {#ehf212871-sec-0003}
=============================================

In this context of pandemic and containment, one could expect a rise in the rate of TTS episodes by an increase of triggering mechanisms such as stress and anxiety, but this remains to be proven. To date, few rare clinical cases report TTS cases during COVID‐19.[^9^](#ehf212871-bib-0009){ref-type="ref"}, [^10^](#ehf212871-bib-0010){ref-type="ref"}

In our tertiary centre, we observed from 1 March 2020 to 15 April 2020 a relatively stable incidence of TTS in comparison to the same period during the previous years. On the contrary, we observed a drop of approximately 30% of the incidence of ACS cases (*Table* [*1*](#ehf212871-tbl-0001){ref-type="table"}). This decline in the number of cases of acute myocardial infarction has been previously highlighted by some authors[^11^](#ehf212871-bib-0011){ref-type="ref"}; however, to the best of our knowledge, no studies to date have described the evolution of the incidence of TTS during the current COVID‐19 outbreak.

###### 

Incidence of cases of ACS and takotsubo syndrome between 1 March and 15 April

          STEMI ACS   Non‐STEMI ACS   ACS (all types)   Takotsubo                                                            
  ------ ----------- --------------- ----------------- ----------- --------- --------- ----- --------- --------- --- ------- -------
  2016       71            Ref             0.016           185        Ref     \<0.001   256     Ref     \<0.001   4    Ref    0.711
  2017       72           0.933                            165       0.285              237    0.392              7   0.372  
  2018       60           0.337                            182       0.876              242    0.53               5   0.739  
  2019       67           0.734                            144       0.024              211    0.038              8   0.258  
  2020       46           0.022                            112      \<0.001             158   \<0.001             5   0.739  

ACS, acute coronary syndrome; non‐STEMI ACS, acute coronary syndrome without ST elevation; *P* ^\*^, 2020 vs. 2016--2019; STEMI ACS, acute coronary syndrome with ST elevation.

Mechanisms of this significant reduction of ACS cases are probably multiple and at least in part common with the absence of a TTS incidence increase during this period. It is likely that a certain number of cases exist but are not visible because (i) patients do not consult for fear of being infected in the hospital or for fear of disturbing the emergency services; (ii) TTS patients are drowned in the middle of calls to emergency and rescue services which are currently overwhelmed; and (iii) minor cases of TTS consulting the emergency department are sent home after a COVID‐19 infection has been ruled out with no further diagnostic procedure such as an electrocardiogram and an echocardiogram which allow identification of TTS.

One could also assume that changes in the emotional and socio‐professional environment could also play a role in this absence of increase in TTS cases (reduction of professional and societal stress: disappearance of traffic jams, reduction in criminal assaults, less social and professional pressure, etc.).

However, if the vast majority of the population is confined and less exposed to TTS triggers, we can assume that some individuals are exposed to stress in this setting: elderly and/or isolated subjects, people exposed to domestic violence, patients with pre‐existing psychiatric conditions or past history of substance abuse, relatives of deceased COVID‐19 patients, and healthcare providers.

In addition, a risk of a rebound phenomenon in the number of TTS cases is plausible during or after the current crisis, due to the likely emergence of numerous cases of major depressive disorders, generalized anxiety, or equivalent of post‐traumatic stress disorder (PTSD) known to be associated with TTS.[^7^](#ehf212871-bib-0007){ref-type="ref"} An increase in PTSD and TTS was noted after terrorist attacks in France in January 2015 and after natural disasters.[^12^](#ehf212871-bib-0012){ref-type="ref"}, [^13^](#ehf212871-bib-0013){ref-type="ref"}, [^14^](#ehf212871-bib-0014){ref-type="ref"}

Awareness of TTS among physicians is therefore necessary. TTS diagnostic algorithms can be used to improve management and eliminate acute coronary syndrome/myocarditis, or identify dysthyroidism or pheochromocytoma.[^8^](#ehf212871-bib-0008){ref-type="ref"}

Conclusions {#ehf212871-sec-0004}
-----------

We observed a stable rate of TTS during the COVID‐19 pandemic in contrast to a decrease in acute coronary syndromes. Late catch up is possible due to the presence of TTS triggers in this setting.
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